HOOKIPA Pharma (NASDAQ:HOOK) Shares Up 3.8% – Here’s What Happened

HOOKIPA Pharma Inc. (NASDAQ:HOOK) shares were up 3.8% on Monday . The company traded as high as $1.09 and last traded at $1.09. Approximately 6,454 shares traded hands during trading, a decline of 32% from the average daily volume of 9,422 shares. The stock had previously closed at $1.05.

HOOKIPA Pharma Trading Up 3.8%

The stock has a market cap of $13.29 million, a PE ratio of -0.19 and a beta of 0.87. The company’s 50 day moving average is $1.03 and its 200-day moving average is $0.94.

HOOKIPA Pharma Company Profile

HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.

In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.